on Eckert & Ziegler Strahlen- Und Medizintechnik AG (ETR:EUZ)
Eckert & Ziegler and TerThera Collaborate to Deliver Terbium-161 Therapies to Brazil
Eckert & Ziegler Brazil and TerThera have signed a strategic agreement to supply Terbium-161, an innovative isotope, to Brazil. This partnership aims to enhance access to radioligand therapies for Brazilian patients. TerThera will provide GMP-compliant Terbium-161, establishing a robust supply chain for the isotope in South America. This move is expected to aid local pharmaceutical developers in exploring new oncological treatments by combining Terbium-161 with advanced agents.
Terbium-161, a promising radionuclide, has been noted for improving anti-tumor capabilities with limited impact on healthy tissue. The isotope's introduction marks a significant step for Eckert & Ziegler, which has a strong presence in Latin America. This agreement underscores their commitment to expanding access to theranostic solutions, offering new clinical possibilities for oncology patients in the region.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Eckert & Ziegler Strahlen- Und Medizintechnik AG news